Brief: New Ray Medicine International Announces Results Of Internal Control Follow-Up Review
27/09/2022 14:17
Sept 27 (Reuters) - New Ray Medicine International
Holding Ltd 6108.HK :
* RESULTS OF INTERNAL CONTROL FOLLOW-UP REVIEW
* INDEPENDENT CONSULTANT IS OF VIEW THAT GROUP IMPLEMENTED
RECOMMENDATIONS MADE BY INDEPENDENT CONSULTANT IN IC REPORT
Source text for Eikon: ID:nHKS1MSWx7
Further company coverage: 6108.HK
Recent news on New Ray Medicine International Holding
See all newsBrief: New Ray Medicine International Holding Says Chu Xueping Resigns As Executive Director
Brief: New Ray Medicine International Posts FY Net Loss Attributable HK$20.1 Million
Brief: New Ray Medicine International To Place Up To 33.4 Million Shares
Brief: New Ray Medicine International Says China New Rich Enters Cooperation Agreement
Brief: New Ray Medicine International Says Unit Disposes 801,000 Jiangxi Rimag Shares For HK$12.8 Million